Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases.

Indian Journal of Dermatology
Siba P Raychaudhuri, Smriti K Raychaudhuri

Abstract

Biologics are becoming important in the treatment of systemic and cutaneous autoimmune diseases. They are designed to target specific components of immune system. As the new drugs are capable of targeting proteins in a more specific fashion, yet have lower risks of systemic side-effects, they have considerable advantages over the older immunomodulators. The development of TNF-alpha blockers in the treatment of psoriasis, psoriatic arthritis, rheumatoid arthritis, Crohn's disease and ankylosing spondylitis have been major breakthroughs. Likewise, B-cell depletion has proved to be equally revolutionary for the treatment of lupus, pemphigus, certain vasculitides etc. But all said and done, the development of these molecules and their clinical usage are still at evolving stages. Consensus needs be formed to further categorize the clinical profiles of the patients in whom biologics are to be used in the future, given that the long-term safety profiles of these agents are very much unknown at present.

References

Jan 1, 1989·Annual Review of Immunology·B Beutler, A Cerami
Oct 1, 1994·The Journal of Experimental Medicine·M J ShlomchikD Huszar
Mar 20, 1998·International Reviews of Immunology·T Hirano
Jan 23, 1999·International Reviews of Immunology·M FeldmannR Maini
May 4, 1999·The Journal of Clinical Investigation·J R AbramsS Kang
May 20, 2003·The British Journal of Dermatology·G G Krueger, C N Ellis
Sep 19, 2003·Cell and Tissue Research·Marc TjwaPeter Carmeliet
Nov 14, 2003·The New England Journal of Medicine·Joel M KremerLarry W Moreland
Nov 25, 2003·The New England Journal of Medicine·Mark LebwohlUNKNOWN Efalizumab Study Group
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group
Dec 10, 2003·The Journal of Experimental Medicine·Craig A MurphyDaniel J Cua
Apr 20, 2004·Current Opinion in Structural Biology·Gongyi Zhang
Jun 18, 2004·The New England Journal of Medicine·Jonathan C W EdwardsTim Shaw
Jul 15, 2004·Current Opinion in Pharmacology·Iain B McInnes, J Alastair Gracie
Sep 25, 2004·Journal of the American Academy of Dermatology·Alice B GottliebAlan Menter
Jun 3, 2005·Nature·Marc Feldmann, Lawrence Steinman
Jun 9, 2005·Seminars in Arthritis and Rheumatism·Marc C HochbergDavid E Yocum
Oct 13, 2006·The Journal of Experimental Medicine·Sophie HueKevin J Maloy
Oct 26, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·A JacobiM Hertl
Oct 27, 2006·The New England Journal of Medicine·A Razzaque AhmedMarshall R Posner
Feb 3, 2007·The Journal of Investigative Dermatology·Philippe AzamHeike Wulff
May 12, 2007·Cytokine & Growth Factor Reviews·Ian A Clark
Nov 21, 2007·Annals of Internal Medicine·Katrina E DonahueKathleen N Lohr
Mar 14, 2008·The Journal of Investigative Dermatology·Siba P RaychaudhuriLeonard A Herzenberg
Mar 20, 2008·The American Journal of Pathology·Siba P RaychaudhuriSmriti K Raychaudhuri

❮ Previous
Next ❯

Citations

Mar 4, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S A Novosad, K L Winthrop
May 18, 2012·Dermatologic Therapy·Naděžda VojáčkováJana Hercogová
Sep 24, 2015·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Sarbani SenguptaBhaskar Ghosh
Oct 1, 2016·Indian Journal of Dermatology·Ankita Srivastava
Jun 24, 2017·Pharmacology & Therapeutics·Rama MalaviyaDebra L Laskin
Apr 10, 2018·Redox Report : Communications in Free Radical Research·Rui LaiJianqiao Zhong
Jun 7, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Mengqin GeXue Li
May 22, 2013·Lupus·D M WaheziUNKNOWN Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators
Jan 19, 2019·Anti-inflammatory & Anti-allergy Agents in Medicinal Chemistry·Amaldoss M J Newton, Prabakaran Lakshmanan
Aug 3, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Luane Macêdo de SousaDelane Viana Gondim
Aug 23, 2019·Therapeutic Advances in Musculoskeletal Disease·Rahul BodkheVeena Taneja
Sep 1, 2017·European Journal of Hospital Pharmacy. Science and Practice·Ana PlanincCédric Delporte
Apr 19, 2011·International Journal of Immunopathology and Pharmacology·O De PitaS Pallotta
May 30, 2020·Expert Opinion on Biological Therapy·Sunil DograMurlidhar Rajagopalan
Apr 4, 2021·International Journal of Molecular Sciences·Dan-In JangSeung-Hoon Yang

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2021 Meta ULC. All rights reserved